Die Medigene AG announced the appointment of Dr. Kai Pinkernell to the Executive Management Board of the company as Chief Medical Officer (CMO) and Chief Development Officer (CDO). Dr. Pinkernell has been with Medigene as Senior Vice President and Chief Medical Officer (CMO) since February 2016. Dr. Kai Pinkernell is responsible for the clinical development, regulatory affairs and manufacturing of Medigene's products. He has 17 years of expertise in global clinical development of cell therapies including preclinical activities, the automation and GMP production as well as in commercialization and business development activities. Before joining Medigene, he held various management positions at Miltenyi Biotech GmbH, Bergisch Gladbach, Germany, most recently as Global Head of Clinical Business and Head of Clinical Development.